---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-195384"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2025-09-04T23:59:59+00:00"
generated_at: "2026-05-17T08:14:54.955843+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Lyra Therapeutics posts corporate presentation; content not detailed in filing extract

## Summary
- Corporate presentation posted on Sept 4, 2025, on Lyra Therapeutics website.
- Company ticker: LYRA (NASDAQ). No other specific updates provided in this filing.
- Presentation may be used in investor discussions; details not available from form text.

## SEC filing metadata
- accession: 0001193125-25-195384
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2025-09-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312525195384/0001193125-25-195384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312525195384/d71675d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-195384
- JSON: https://secwatch.observer/filing/0001193125-25-195384.json
- Plain text: https://secwatch.observer/filing/0001193125-25-195384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.